Maged P. Ghali M.D. Professor & Chief, Division of Gastroenterology; Program Director, Gastroenterology Fellowship Department: Department of Medicine Business Phone: (904) 633-0798 Business Email: Maged.Ghali@jax.ufl.edu Appointments and Locations Board Certifications Internal MedicineGastroenterologyTransplant Hepatology Show More Clinical Profile Specialties Gastroenterology Languages Speaks English and French Show More Publications 2021Esophageal Perforation after Using a Single-Use Disposable Duodenoscope.Case reports in gastroenterology.15(3):972-977[DOI] 10.1159/000519685.[PMID] 35110984.2 citations·PubMed·Publisher's Site2020Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.BMJ case reports.13(6):-[DOI] 10.1136/bcr-2020-234637.[PMID] 32601138.PubMed·Publisher's Site2019What Patients Want in a Smartphone App That Supports Colonoscopy Preparation: Qualitative Study to Inform a User-Centered Smartphone AppJMIR mHealth and uHealth.7(7):e12242-[DOI] 10.2196/12242.[PMID] 31125310.7 citations·PubMed·Publisher's Site2017Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant RecipientsCanadian Journal of Gastroenterology and Hepatology.2017():1-8[DOI] 10.1155/2017/4381864.[PMID] 28409147.1 citations·PubMed·Publisher's SiteWhat Patients Want in a Smartphone App That Supports Colonoscopy Preparation: Qualitative Study to Inform a User-Centered Smartphone App (Preprint).():-[DOI] 10.2196/preprints.12242.[PMID] .PubMed·Publisher's Site Show More Office Information Academic Office Building 1, Suite 3004555 Emerson StreetJacksonville, FL 32207(904) 633-0797 Maged.Ghali@jax.ufl.edu Administrative Manager Joann Feliciano(904) 633-0798Joann.feliciano@jax.ufl.edu GME Office 5th Floor, Tower 1580 West 8th Street, Suite 513Jacksonville, FL 32209Phone: (904) 244-3092 Maged.Ghali@jax.ufl.edu Program Administrator Jessica McDonald-Jazrawi, MBA, C-TAGME(904) 244-3092jessica.mcdonald-jazrawi2@jax.ufl.edu Show More Clinical Research OPEN ENROLLMENT A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis TARGET-HCC: A 5 - year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma OPEN ENROLLMENT A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease OPEN ENROLLMENT A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis Education Medical Degree1998 · McGill University, Montreal, CanadaInternal Medicine Residency2001 · McGill University Health Center -Royal Victoria Hospital, Montreal, CanadaGastroenterology Fellowship2004 · McGill University Health Center -Royal Victoria Hospital, Montreal, CanadaTransplant Hepatology Fellowship2005 · Mayo Clinic, Rochester, MN, USA Show More Media Coverage March 29, 2022 Study: Cancer numbers declining due to people not getting screened, warns patients can have worse outcomes First Coast News